Abt 263 navitoclax
ABT-263 (Navitoclax) is a laboratory research compound developed by Selleck Chemicals. It functions as a selective inhibitor of the anti-apoptotic Bcl-2 family proteins.
Lab products found in correlation
16 protocols using abt 263 navitoclax
Synthesis and Evaluation of Novel Anticancer Compounds
Murine Myeloid Cell Culture Protocols
RPMI-1640 AQmedia, propidium iodide (PI) and Eukitt were purchased from Sigma-Aldrich Chemie GmbH (Buchs, Switzerland). Fetal calf serum (FCS, Sera Pro, ultra-low endotoxin) was purchased from Pan Biotech (Aidenbach, Germany). 2-mercaptoethanol (2-ME), 4-hydroxytamoxifen (4-OHT), and penicillin/streptomycin were from Life Technologies (Carlsbad, CA, USA). WEHI-3B cell-conditioned medium was used as a source of mouse interleukin-3 and was produced as previously described.27 (link), 50 (link) Recombinant mouse IL-3 was purchased from Peprotech (London, UK). Q-VD-OPh was purchased from SM Biochemicals (Anaheim, CA, USA). Recombinant His6-tagged GFP-Annexin V was purified in-house as previously described.51 (link), 52 (link) Pancoll human (density 1.077 g/ml) was purchased from Pan Biotech, while EasySep Human Basophil Enrichment Kit was bought from StemCell Technologies (Vancouver, Canada). ABT-199 (Venetoclax) was manufactured by BioVision (Milpitas, CA, USA), ABT-263 (Navitoclax) and A-1210477 by Selleck Chemicals (Houston, TX, USA), while WEHI-539 hydrochloride was purchased from Hycultec (Beutelsbach, Germany).
Breast Cancer Cell Line Characterization
Induction and Inhibition of Cell Death Pathways
Cytotoxic Treatments for Renal Cell Carcinoma
Senolytic ABT263/Navitoclax Treatment
Activation of Apoptotic Pathways in Mice
RPMI-1640 AQmedia™, propidium iodide (PI), 4-hydroxytamoxifen (4-OHT), and SMI-4a were purchased from Sigma-Aldrich Chemie GmbH (Buchs, CH). Fetal calf serum (FCS, Sera Pro, ultra-low endotoxin) was purchased from Pan Biotech (Aidenbach, DE), penicillin–streptomycin from Gibco (Thermo Fisher Scientific, Waltham, MA, US). As a source of mouse IL-3, WEHI-3B cell-conditioned medium was used and produced as previously described21 (link),48 (link). Recombinant mouse IL-4, IL-3, IL-33, and IL-13 were purchased from Peprotech (London, UK). Q-VD-OPh was purchased from SM Biochemicals (Anaheim, CA, US). ABT-199 (Venetoclax/Venclexta) was manufactured by BioVision (Milpitas, CA, US), ABT-263 (Navitoclax) by Selleck Chemicals (Houston, TX, US), WEHI-539 hydrochloride was purchased from Hycultec (Beutelsbach, DE), S63845 from ApexBio (Houston, TX, US). Recombinant His6 (link)-tagged GFP-Annexin V was purified as previously described49 (link),50 (link). LY-294002 and rapamycin were from Enzo Life Science (Lausen, CH).
Apoptosis Regulating Compounds Protocol
BH3-Mimetics Sensitivity Assay
Apoptosis-Inducing Compound Screening
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!